BioCentury
ARTICLE | Clinical News

PhotoCure reports Phase II Hexvix data

August 17, 2001 7:00 AM UTC

PhotoCure (OSE:PHO) said that its Hexvix fluorescence cystoscopy was superior to white light cystoscopy in diagnosing bladder cancer in a Phase II study of 52 patients with known or suspected bladder ...